Analysis of NUDT15 gene polymorphism in inflammatory bowel disease patients

Analysis of NUDT15 gene polymorphism in inflammatory bowel disease patients - Analysis of NUDT15 gene polymorphism in inflammatory bowel disease patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018675

Enrollment

200

Registered

2015-08-17

Start date

2015-06-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: inflammatory bowel disease(IBD) patients

Exclusion criteria

Exclusion criteria: 1)pregnancy 2)history of drug allergy 3)patients not approving the study consent

Design outcomes

Primary

Measure	Time frame
NUDT15 gene polymorphism is analyzed.And WBC count(2,4,8weeks),Interval from onset of AZA/6MP therapy to leukopenia, AZA/6MP dose is evaluated.	—

Countries

Japan

Contacts

Public ContactAtsushi Nishida

Shiga University of Medical Science Division of Gastroenterology

atsuda@belle.shiga-med.ac.jp077-548-2217

Outcome results